{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:32:35Z","timestamp":1789551155121,"version":"build-2803163510"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1001\/jamapsychiatry.2020.1624","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:11:39Z","timestamp":1594829499000},"page":"1163","source":"Crossref","is-referenced-by-count":76,"title":["Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US"],"prefix":"10.1001","volume":"77","author":[{"given":"Robert A.","family":"Kleinman","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"yoi200037r1","journal-title":"BMJ"},{"issue":"6","key":"yoi200037r4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1377\/hlthaff.2014.1205","article-title":"Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002-11.","volume":"34","author":"Dick","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"13","key":"yoi200037r7","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 US states.","volume":"322","author":"Joudrey","year":"2019","journal-title":"JAMA"},{"key":"yoi200037r8","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/948789","article-title":"Distance traveled and cross-state commuting to opioid treatment programs in the United States.","volume":"2011","author":"Rosenblum","year":"2011","journal-title":"J Environ Public Health"},{"key":"yoi200037r9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107968","article-title":"Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: a cross-sectional study.","volume":"211","author":"Joudrey","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"yoi200037r10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0740-5472(03)00188-0","article-title":"Distance traveled to outpatient drug treatment and client retention.","volume":"25","author":"Beardsley","year":"2003","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"yoi200037r11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone matters: what the United States can learn from the global effort to treat opioid addiction.","volume":"34","author":"Calcaterra","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"29","key":"yoi200037r16","first-page":"56277","article-title":"Census tracts for the 2020 census\u2014final criteria.","volume":"83","author":"Bureau of the Census, Department of Commerce","year":"2018","journal-title":"Fed Regist"},{"issue":"15","key":"yoi200037r18","first-page":"3433","article-title":"HIPAA administrative simplification: standard unique health identifier for health care providers: final rule.","volume":"69","author":"Centers for Medicare & Medicaid Services, HHS","year":"2004","journal-title":"Fed Regist"},{"issue":"6","key":"yoi200037r33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198173","article-title":"Mapping pharmacy deserts and determining accessibility to community pharmacy services for elderly enrolled in a State Pharmaceutical Assistance Program.","volume":"13","author":"Pednekar","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"yoi200037r34","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1377\/hlthaff.2013.1397","article-title":"\u2018Pharmacy deserts\u2019 are prevalent in Chicago\u2019s predominantly minority communities, raising medication access concerns.","volume":"33","author":"Qato","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"yoi200037r35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ypmed.2015.04.017","article-title":"Interim treatment: Bridging delays to opioid treatment access.","volume":"80","author":"Sigmon","year":"2015","journal-title":"Prev Med"},{"issue":"1","key":"yoi200037r36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMp1803982","article-title":"Methadone in primary care\u2014one small step for Congress, one giant leap for addiction treatment.","volume":"379","author":"Samet","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"yoi200037r41","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1111\/add.2007.102.issue-11","article-title":"Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.","volume":"102","author":"Sheridan","year":"2007","journal-title":"Addiction"},{"issue":"1","key":"yoi200037r44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.2019.35.issue-1","article-title":"Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update.","volume":"35","author":"Andrilla","year":"2019","journal-title":"J Rural Health"},{"key":"yoi200037r45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.04.029","article-title":"Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies.","volume":"191","author":"Gauthier","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"yoi200037r46","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/ajad.v27.8","article-title":"Expanding access to buprenorphine treatment in rural areas with the use of telemedicine.","volume":"27","author":"Weintraub","year":"2018","journal-title":"Am J Addict"},{"issue":"1","key":"yoi200037r47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archpsyc.63.1.102","article-title":"A randomized controlled trial of interim methadone maintenance.","volume":"63","author":"Schwartz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"yoi200037r2","volume-title":"Federal Guidelines for Opioid Treatment Programs","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"yoi200037r5","volume-title":"ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","author":"American Society of Addiction Medicine (ASAM)","year":"2015"},{"key":"yoi200037r6","author":"Substance Abuse and Mental Health Services Administration"},{"key":"yoi200037r12","author":"Institute of Medicine Committee on Federal Regulation of Methadone Treatment","year":"1995"},{"key":"yoi200037r13"},{"key":"yoi200037r19","volume-title":"2013 NCHS Urban-Rural Classification Scheme for Counties","author":"Ingram","year":"2014"},{"key":"yoi200037r22","volume-title":"ArcMap software. Version 10.7.1","author":"ESRI","year":"2019"},{"key":"yoi200037r23","volume-title":"StreetMap Premium for ArcGIS North America 2019; Release 3","author":"ESRI","year":"2019"},{"key":"yoi200037r39","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"yoi200037r3","unstructured":"Substance Abuse and Mental Health Services Administration. Opioid treatment program directory. Accessed February 3, 2020. https:\/\/dpt2.samhsa.gov\/treatment\/directory.aspx"},{"key":"yoi200037r14","unstructured":"Kleinman? RA. Protocol driving times. Accessed on June 13, 2020. https:\/\/github.com\/rkleinman\/Protocol_Driving_Times"},{"key":"yoi200037r15","unstructured":"US Census Bureau. Centers of Population for the 2010 Census. Accessed October 11, 2019. https:\/\/www.census.gov\/geographies\/reference-files\/2010\/geo\/2010-centers-population.html"},{"key":"yoi200037r17","unstructured":"NPI Files. Accessed February 3, 2020. https:\/\/download.cms.gov\/nppes\/NPI_Files.html"},{"key":"yoi200037r20","unstructured":"Economic Research Service, United States Department of Agriculture. Rural-urban commuting area codes. Accessed April 17, 2020. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/"},{"key":"yoi200037r21","unstructured":"Economic Research Service, United States Department of Agriculture. Documentation: 2010 Rural-Urban Commuting Area (RUCA) Codes. Accessed April 17, 2020. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/documentation\/"},{"key":"yoi200037r24","unstructured":"ESRI. About geocoding a table of addresses. Accessed April 15, 2020. https:\/\/desktop.arcgis.com\/en\/arcmap\/latest\/manage-data\/geocoding\/geocoding-a-table-of-addresses-about.htm"},{"key":"yoi200037r25","unstructured":"Veness? C. Calculate distance, bearing and more between latitude\/longitude points. 2020. Accessed June 7, 2020. https:\/\/www.movable-type.co.uk\/scripts\/latlong.html"},{"key":"yoi200037r26","unstructured":"ESRI. More accurate geocoding and routing with StreetMap Premium. Accessed November 23, 2019. https:\/\/www.esri.com\/about\/newsroom\/arcnews\/more-accurate-geocoding-and-routing-with-streetmap-premium\/"},{"key":"yoi200037r27","unstructured":"Internal Revenue Service. IRS issues standard mileage rates for 2019. IR-2018-251. Accessed December 1, 2019.  https:\/\/www.irs.gov\/newsroom\/irs-issues-standard-mileage-rates-for-2019"},{"key":"yoi200037r28","unstructured":"Federal Highway Administration. Highway statistics 2017. Accessed March 9, 2019. https:\/\/www.fhwa.dot.gov\/policyinformation\/statistics\/2017\/vm1.cfm"},{"key":"yoi200037r29","unstructured":"US Energy Information Administration. State Energy Data System (SEDS): 1960-2017 (complete). Accessed November 28, 2019. https:\/\/www.eia.gov\/state\/seds\/seds-data-complete.php?sid=US#CompleteDataFile"},{"key":"yoi200037r30","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing; 2019. Accessed June 7, 2020. https:\/\/www.R-project.org\/"},{"key":"yoi200037r31","unstructured":"Di Lorenzo? P. usmap. Last updated August 22, 2019. Accessed June 7, 2020. https:\/\/github.com\/pdil\/usmap\/blob\/master\/R\/transform.R"},{"key":"yoi200037r32","unstructured":"Rudis? B. Modified US Albers projections for R (moving Alaska & Hawaii). Accessed March 9, 2020. https:\/\/github.com\/hrbrmstr\/rd3albers"},{"key":"yoi200037r37","unstructured":"Vestal? C. Federal ban on methadone vans seen as barrier to treatment. Accessed December 14, 2019. https:\/\/pew.org\/2HVB4Ei"},{"key":"yoi200037r38","unstructured":"Methadone barriers persist, despite decades of evidence. Health Affairs. Accessed December 14, 2019. https:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20190920.981503\/full\/"},{"key":"yoi200037r40","unstructured":"Substance Abuse and Mental Health Services Administration. Medication units webinar. Accessed December 16, 2019. https:\/\/www.samhsa.gov\/sites\/default\/files\/programs_campaigns\/medication_assisted\/webinar-transcript-medication-units.pdf"},{"key":"yoi200037r42","unstructured":"Australian Institute of Health and Welfare. Data tables: national opioid pharmacotherapy statistics annual collection 2019. Accessed April 15, 2020. https:\/\/www.aihw.gov.au\/reports\/alcohol-other-drug-treatment-services\/national-opioid-pharmacotherapy-statistics-2019\/data"},{"key":"yoi200037r43","unstructured":"PBS Information Management Section. PBS expenditure and prescriptions report: 1 July 2018 to 30 June 2019. Australian Dept of Health. Accessed April 15, 2020. http:\/\/www.pbs.gov.au\/statistics\/expenditure-prescriptions\/2018-2019\/PBS_Expenditure_and_Prescriptions_Report_1-July-2018_to_30-June-2019.pdf"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2768026\/jamapsychiatry_kleinman_2020_oi_200037_1603916084.63503.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T16:49:44Z","timestamp":1604508584000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2768026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.1624","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}